港股異動 | 康希諾生物-B急升逾10%,B股跟隨拉升,開拓藥業-B升逾6%
uSMART友信智投5月22日消息,週五港股早市,康希諾生物-B低開高走,截至北京時間9時58分,康希諾生物-B升10%,報235.4港元。
圖片來源:uSMART友信智投
B股也跟隨康希諾生物-B的步伐,市中拉升,截至北京時間10時02分,開拓藥業升6.45%,康方生物-B升1.48%,諾誠健華-B升1.62%,沛嘉醫療-B升0.81%。




圖片來源:uSMART友信智投
昨日午後,康希諾生物-B突然"高台跳水",由升轉跌,振幅高達30%(詳情閱讀uSMART友信智投昨日報導的《港股異動 | "今年港股冠軍"康希諾生物-B午後突然跳水20%》),康希諾生物-B突然跳水,帶領B股集體向下。
對於這個突然的跳水,康希諾生物-B昨晚在港交所披露公告稱,康希諾生物在港交所公告,本公司已知悉本公司近日股份價格波動。本公司運營正常,並不知悉導致價格波動的任何明確原因,或任何必須公佈以避免本公司股份出現虛假市場的資料。
免責聲明:本文所載的所有資料、資料等(「資料」)只供參考之用,不構銷售或建議任何投資、交易策略或金融產品的要約或招攬。本公司會盡力確保資料的準確性及可靠性, 但不保證該資料為準確無誤, 亦不承擔因任何不準確或遺漏而引起的損失或損害。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.